116 related articles for article (PubMed ID: 15023480)
1. Bupropion and paroxetine differentially influence cardiovascular and neuroendocrine responses to stress in depressed patients.
Straneva-Meuse PA; Light KC; Allen MT; Golding M; Girdler SS
J Affect Disord; 2004 Apr; 79(1-3):51-61. PubMed ID: 15023480
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
3. Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal.
Kotlyar M; Brauer LH; al'absi M; Adson DE; Robiner W; Thuras P; Harris J; Finocchi ME; Bronars CA; Candell S; Hatsukami DK
Pharmacol Biochem Behav; 2006 Mar; 83(3):370-9. PubMed ID: 16581115
[TBL] [Abstract][Full Text] [Related]
4. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension.
Thase ME; Haight BR; Johnson MC; Hunt T; Krishen A; Fleck RJ; Modell JG
J Clin Psychopharmacol; 2008 Jun; 28(3):302-7. PubMed ID: 18480687
[TBL] [Abstract][Full Text] [Related]
6. Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects.
Brunswick DJ; Goodman DB; O'Reardon JP; Chopra M; Amsterdam JD
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):477-80. PubMed ID: 15093954
[TBL] [Abstract][Full Text] [Related]
7. Assessing the effects of bupropion SR on mood dimensions of depression.
Tomarken AJ; Dichter GS; Freid C; Addington S; Shelton RC
J Affect Disord; 2004 Mar; 78(3):235-41. PubMed ID: 15013248
[TBL] [Abstract][Full Text] [Related]
8. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions.
Rechlin T; Weis M; Claus D
Pharmacopsychiatry; 1994 May; 27(3):124-8. PubMed ID: 8078953
[TBL] [Abstract][Full Text] [Related]
9. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.
Rechlin T
J Clin Psychopharmacol; 1994 Dec; 14(6):392-5. PubMed ID: 7884019
[TBL] [Abstract][Full Text] [Related]
10. Effect of paroxetine on physiological response to stress and smoking.
Kotlyar M; al'Absi M; Thuras P; Vuchetich JP; Adson DE; Nowack AL; Hatsukami DK
Psychosom Med; 2013 Apr; 75(3):236-43. PubMed ID: 23504241
[TBL] [Abstract][Full Text] [Related]
11. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia.
Gold PW; Wong ML; Goldstein DS; Gold HK; Ronsaville DS; Esler M; Alesci S; Masood A; Licinio J; Geracioti TD; Perini G; DeBellis MD; Holmes C; Vgontzas AN; Charney DS; Chrousos GP; McCann SM; Kling MA
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8303-8. PubMed ID: 15919819
[TBL] [Abstract][Full Text] [Related]
12. The cardiovascular profile of bupropion.
Wenger TL; Stern WC
J Clin Psychiatry; 1983 May; 44(5 Pt 2):176-82. PubMed ID: 6406453
[TBL] [Abstract][Full Text] [Related]
13. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
[TBL] [Abstract][Full Text] [Related]
14. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression.
Ahrens T; Deuschle M; Krumm B; van der Pompe G; den Boer JA; Lederbogen F
Psychosom Med; 2008 May; 70(4):461-7. PubMed ID: 18378864
[TBL] [Abstract][Full Text] [Related]
15. Effect of paroxetine and bupropion on human resting brain perfusion: an arterial spin labeling study.
Viviani R; Abler B; Seeringer A; Stingl JC
Neuroimage; 2012 Jul; 61(4):773-9. PubMed ID: 22446490
[TBL] [Abstract][Full Text] [Related]
16. Depression and stress reactivity in metastatic breast cancer.
Giese-Davis J; Wilhelm FH; Conrad A; Abercrombie HC; Sephton S; Yutsis M; Neri E; Taylor CB; Kraemer HC; Spiegel D
Psychosom Med; 2006; 68(5):675-83. PubMed ID: 17012520
[TBL] [Abstract][Full Text] [Related]
17. Salt-sensitive men show reduced heart rate variability, lower norepinephrine and enhanced cortisol during mental stress.
Weber CS; Thayer JF; Rudat M; Sharma AM; Perschel FH; Buchholz K; Deter HC
J Hum Hypertens; 2008 Jun; 22(6):423-31. PubMed ID: 18337758
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
[TBL] [Abstract][Full Text] [Related]
19. Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety.
Muigg P; Hoelzl U; Palfrader K; Neumann I; Wigger A; Landgraf R; Singewald N
Biol Psychiatry; 2007 Mar; 61(6):782-96. PubMed ID: 17224133
[TBL] [Abstract][Full Text] [Related]
20. Chronic stress influences cardiovascular and neuroendocrine responses during acute stress and recovery, especially in men.
Matthews KA; Gump BB; Owens JF
Health Psychol; 2001 Nov; 20(6):403-10. PubMed ID: 11714181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
